In compliance with current laws and regulations, Ulisse BioMed has approved an internal dealing procedure aimed at guaranteeing transparency on relevant transactions concerning the purchase or sale of company shares in the direct or indirect possession of persons able to influence company decisions or in any case in possession of information capable of raising awareness of the stock's performance on the markets.

This section contains communications and notifications received by Relevant Persons, as defined in the procedure.

Download the template for notification and public disclosure of transactions carried out by persons exercising administrative, control or management functions and persons closely associated with them.